|
Post by stayingpositive on Sept 18, 2009 22:13:24 GMT 1
This is very interesting too... news.bbc.co.uk/1/hi/health/7629753.stmbreakdown of PCTs over England who fund Tarceva The BBC contacted all Primary Care Trusts in England, Local Health Boards in Wales, and the NHS in Scotland and Northern Ireland. Focusing on five specific drugs not officially approved for use on the NHS, we asked how many applications they had received from patients in the last financial year - and how many had been granted. The drugs in question were, Avastin, for colon and breast cancer, Erbitux, for colon and lung cancer, Nexavar, for renal and liver cancer, Sutent, for renal cancer, and Tarceva, for lung and pancreatic cancer. Access to the drugs was tightest in London, and easiest in the North West of England. However, there were wide variations, even between neighbouring authorities and in some areas no requests for the drugs had been made.
|
|
|
Post by stayingpositive on Sept 19, 2009 0:04:27 GMT 1
|
|